Related Experiment Video
Updated: Jun 5, 2025
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Prevalence of thrombosis in patients undergoing dialysis treatment: A systematic review and meta-analysis
Parisa Shiri1, Shabab Rezaeian2, Alireza Abdi3
1Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Aim:
to determine the prevalence of thrombosis in dialysis patients.
Background:
Thrombosis is the most common cause of vascular access dysfunction in dialysis patients. Various studies have reported different prevalence rates of thrombosis, and no systematic study provides a comprehensive result on this subject.
Methods:
In this systematic review and meta-analysis, a search of available texts was conducted until the end of December 2023, using keywords such as Thrombosis, end-stage renal disease, end-stage kidney disease, hemodialysis, and dialysis in databases including Web of Science, PubMed, Scopus, ProQuest, Ovid, Science Direct, Clinical Key, EMBASE, CINAHL, SID, and MagIran. The random-effects model was used, and the heterogeneity of the studies was assessed using the I2 index. The quality of the selected studies was evaluated using the STROBE checklist. Meta-analysis was performed using CMA version 2 and STATA version 14 software. The study adhered to the guidelines stated in the PRISMA statement.
Results:
Out of 12,604 articles found, after removing duplicates and conducting evaluations, the full text of 415 articles was examined, and ultimately, 141 articles were included in the study. The overall prevalence of thrombosis was 14.2% (95% CI: 11.5-17.2). The prevalence of thrombosis was higher in dialysis patients under 50 years of age (17.1%, 95% CI: 11.3-23.8) and patients with vascular access (16.2%, 95% CI: 13.1-19.5), especially arteriovenous grafts (22.8%, 95% CI: 14.5-32.4). Additionally, the prevalence of late thrombosis was higher than that of early thrombosis (15.0% vs. 5.3%) (95% CI: 7.7-24.2 vs. 95% CI: 2.7-8.5).
Conclusions:
The results indicate a relatively high prevalence of thrombosis in dialysis patients. The prevalence of thrombosis in patients with arteriovenous grafts was notable. Considering the risks of thrombosis, the adoption of preventive measures in hemodialysis patients, such as the use of anticoagulant drugs, is recommended.
Related Concept Videos
01:27Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
01:24Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:17Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
01:20Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
01:22Heart Failure Drugs: Diuretics